Development of an artificial intelligence-derived histologic signature associated with adjuvant gemcitabine treatment outcomes in pancreatic cancer

By sjmartinez • April 13, 2023

Nimgaonkar V, Krishna V, Krishna V, Tiu E, Joshi A, Vrabac D, Bhambhvani H, Smith K, Johansen JS, Makawita S, Musher B, Mehta A, Hendifar A, Wainberg Z, Sohal D, Fountzilas C, Singhi A, Rajpurkar P, Collisson EA. Development of an artificial intelligence-derived histologic signature associated with adjuvant gemcitabine treatment outcomes in pancreatic cancer. Cell Rep Med. 2023 Apr 5:101013. doi: 10.1016/j.xcrm.2023.101013. Epub ahead of print. PMID: 37044094.

Tags: digital pathology, Hematology/Oncology, pancreatic cancer, Predictive biomarker, Publications

Extranodal diffuse large B-cell lymphoma presenting with extensive organ involvement

Kim K, Ziyeh S, Kim P. Extranodal diffuse large B-cell lymphoma presenting with extensive organ involvement. BMJ Case Rep. 2024 Jun 30;17(6):e257416. doi: 10.1136/bcr-2023-257416. PMID:[...]

Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment

Glaviano A, Wander SA, Baird RD, Yap KC, Lam HY, Toi M, Carbone D, Geoerger B, Serra V, Jones RH, Ngeow J, Toska E, Stebbing[...]

Childhood Adversities and the ATTACH TM Program’s Influence on Immune Cell Gene Expression

Yu Z, Cole S, Ross K, Hart M, Anis L, Letourneau N. Childhood Adversities and the ATTACHTM Program's Influence on Immune Cell Gene Expression. Int J[...]